Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/16/25 08:19 | 10/15/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Gerber Hans-Peter | CA | O | CHIEF SC | 2 | P.d | 14 | 0.2497 | 0 | 55 | 314 | 72 | D | ||||||||||||||
10/16/25 08:18 | 10/15/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Chow Gregory K. | CA | O | CFO | 1 | P | 16 | 0.8100 | 0 | 20 | 20 | D | |||||||||||||||
10/16/25 08:17 | 10/15/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Chung Jane | CA | DO | CEO | 2 | P.d | 10 | 0.3204 | 0 | 31 | 34 | 123 | D | ||||||||||||||
10/16/25 08:15 | 10/15/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Matsui Connie | CA | D | 1 | P | 40 | 0.7990 | 0 | 50 | 50 | D | ||||||||||||||||
10/16/25 08:14 | 10/15/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Pauling David | CA | O | Chief Ad | 1 | P | 10 | 0.7992 | 0 | 13 | 21 | 72 | D | ||||||||||||||
8/26/25 21:21 | 7/8/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Leyman Barbara | CA | O | Chief Bu | 1 | M.d | 0 | 0.00 | 0 | 25 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |